Celltrion, Inc. Completes EU Launch of 'Aptozma' 김새미 2026.01.30 오전 10:44 Celltrion Posts Record Q2 Results, Accelerates Global Pharma Ambitions 나은경 2025.07.24 오전 10:58 Celltrion Posts Record-High Q2 Earnings with 235% Surge in Operating Profit 송영두 2025.07.21 오전 10:03 Celltrion’s Yuflyma Hits 24% in Europe on Direct Sales Strength 김새미 2025.08.04 오전 10:33 Bio&Pharma Stocks: BL Pharmtech, Celltrion and Amicogen on the Rise 임정요 2025.02.27 오전 08:33 Remsima SC Captures 22% of European Market, 5 Fold Growth in 4 Years 송영두 2025.05.28 오전 10:01 Celltrion forecasts record Q4 results on strong profit growth 송영두 2025.12.31 오전 09:08 Celltrion's Remsima becomes S.Korea's first 'blockbuster' drug 임정요 2025.02.27 오전 08:36 Celltrion, Track to Achieve 5 Trillion won in Annual Revenue This Year with Successful U.S. Expan... 신민준 2025.03.06 오전 10:10 로딩중..
RemsimaSC
RemsimaSC
